CELU vs GILD: Which Stock is Better?
Side-by-side comparison of Celularity Inc and Gilead Sciences Inc in 2026
CELU
Celularity Inc
$1.25
GILD
Gilead Sciences Inc
$138.55
Key Metrics Comparison
| Metric | CELU | GILD | Winner |
|---|---|---|---|
| Market Cap | $37.49M | $173.48B | GILD |
| P/E Ratio | N/A | 20.61 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.4% | 0.0% | GILD |
| Gross Margin | 50.6% | 78.8% | GILD |
Analyze CELU
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CELU or GILD a better investment?
Comparing CELU and GILD: Celularity Inc has a market cap of $37.49M while Gilead Sciences Inc has $173.48B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CELU and GILD?
CELU (Celularity Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CELU or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CELU or GILD?
GILD has higher revenue growth at 0.0% vs -0.4% for CELU.
Which company is more profitable: CELU or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 50.6% for CELU.
Which is the larger company: CELU or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $173.48B compared to $37.49M for CELU.
Should I buy CELU or GILD in 2026?
Both CELU and GILD have investment merit. CELU trades at $1.25 while GILD trades at $138.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CELU and GILD stock?
Key differences: Market Cap ($37.49M vs $173.48B), P/E Ratio (N/A vs 20.6x), Revenue Growth (-0.4% vs 0.0%), Gross Margin (50.6% vs 78.8%).